ZOE (personalized nutrition company)
A health science company delivering personalized nutrition guidance through microbiome testing, CGMs, and AI-driven dietary recommendations.
ZOE – About ZOEZOE is a London-founded health science company that operates at the intersection of microbiome science, machine learning, and consumer health. It was co-founded by Professor Tim Spector (King's College London), CEO Jonathan Wolf (formerly CPO at Criteo), and President George Hadjigeorgiou. The company's mission is to improve the health of millions through scientifically grounded, personalized nutrition.
ZOE's direct-to-consumer model begins with an at-home test kit ($294 in the US) covering gut microbiome analysis, a continuous glucose monitor, and a blood fat test. Results feed into personalized dietary recommendations delivered via a subscription app ($59.99/month), with gamified food scores and regular retesting built into the experience.
The company has published over 60 peer-reviewed papers over seven years, collaborating with researchers at Massachusetts General Hospital, Stanford Medicine, Harvard T.H. Chan School of Public Health, and King's College London. A randomized controlled trial on personalized nutrition and cardiometabolic health was published in Nature Medicine in May 2024. ZOE has over 100,000 members and has raised $118 million in total funding, including a $15 million Series B extension in July 2024 aimed at US market expansion.
ZOE also runs a top-rated podcast, ZOE Science & Nutrition, which serves as a significant discovery channel. An innovation in personalized nutrition, microbiome science, or consumer health technology would be directly relevant to ZOE's core product, research pipeline, and growth strategy.